Skip to content
My WebMD Sign In, Sign Up
Select An Article

This article is from the WebMD Feature Archive

Font Size

Is Prostate Cancer Screening Still Necessary?

The current test for prostate cancer continues to spark debate. In part 1 of WebMD's 2-part series, there's important prostate cancer information that men should have.

Understanding Prostate Cancer and the PSA Exam continued...

The role of the prostate is to produce a substance that mixes with sperm to create semen. Prostate cells also secrete a number of proteins, including prostate specific antigen, or PSA.

"It's important to note that both normal prostate cells and malignant prostate cells produce PSA," says Chinnaiyan.

So how does the PSA relate to prostate cancer?

Experts say a small amount of PSA is always leaked into the bloodstream. Just how much is found in the blood is then used to determine the risk of prostate cancer.

While it seems like a straightforward association, it's not. The reason: According to urologist Simon Hall, MD, there are some men with a very aggressive prostate cancer whose PSA levels are normal. Likewise, there are men whose PSA levels are soaring but who are cancer-free. And right now, no one is sure why.

Still, he tells WebMD, "It's important for men to understand that the PSA does not diagnose cancer; it helps to create a risk profile. It only tells you if your risk is increased," says Hall, chairman of the department of urology at the Mount Sinai School of Medicine in New York City. And, he says, when interpreted properly, it can do just that.

To help further define those risks, doctors frequently perform a second exam known as the DRE or digital rectal exam. In this test the doctor manually examines the prostate through the rectum, checking for shape, symmetry, hardness, and size.

The Prostate Cancer Biopsy: Your Ultimate Diagnostic

Depending on the findings of both the DRE and PSA screenings, the final diagnostic step is frequently a biopsy or sampling of the cells inside the prostate. In this procedure, Lepor says, 12 to 14 cores [cell samples] are removed and tested for the presence of cancer cells and their type, size, and aggressiveness (how fast they are growing).

The method of notating this measurement is called the Gleason score, and it ranges from 2 (known as an incidental cancer and probably slow growing) to 10 (which indicates a highly aggressive cancer with imminent health threats).

But as effective as the biopsy can be in determining both risks and treatment choices, Lepor points out that it doesn't always render clear-cut results.

"It's entirely possible for the sampling to pull up cells that indicate only a moderate or even incidental cancer when right next door there could be more aggressive cells," he says.

If the decision is then made to remove the prostate, and no more aggressive cells are found, then the surgery might have been unnecessary. But at the same time, he says, not doing the surgery -- and missing the aggressive cells -- could mean death.

But rather than blame the PSA for the unnecessary procedures, both Hall and Lepor say it can aid in making the right treatment decision.

"While the PSA does not yield a cancer diagnosis on its own, together with other pieces of information it forms a risk profile, and it is that risk profile that can be very important when determining an individual man's course of treatment," says Hall.

Next Article:

Today on WebMD

Prostate Cancer Overview
what is your cancer risk
woman speaking with doctor
Prostate Nerve Transplant
cancer fighting foods
15 Cancer Symptoms Men Ignore
Prostate Enlarged
Picture Of The Prostate
Prostate Cancer Quiz
screening tests for men
Prostate Cancer Symptoms
Vitamin D